Anavex Life Sciences Corp.
AVXL
$9.45
-$0.085-0.89%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -48.17M | -47.14M | -46.49M | -43.00M | -41.53M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 9.90M | 8.00M | 9.21M | 9.44M | 10.55M |
Change in Net Operating Assets | 1.17M | 9.32M | 1.67M | 2.75M | 972.00K |
Cash from Operations | -37.10M | -29.81M | -35.61M | -30.81M | -30.00M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 1.77M | 6.20M | 12.62M | 11.98M | 13.94M |
Repurchase of Common Stock | -2.26M | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -494.00K | 6.20M | 12.62M | 11.98M | 13.94M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -37.59M | -23.62M | -22.99M | -18.84M | -16.06M |